Evidence map›Paper›PMID 33503881›Full record

ArticleInternational journal of molecular sciences2021

Glutamine Uptake via SNAT6 and Caveolin Regulates Glutamine-Glutamate Cycle.

Nikhil R Gandasi, Vasiliki Arapi, Michel E Mickael, Prajakta A Belekar, Louise Granlund, Lakshmi Kothegala, Robert Fredriksson, Sonchita Bagchi

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Nikhil R GandasiDepartment of Metabolic Physiology, Institute of Neuroscience and Physiology, University of Göteborg, Box 430, SE-405 30 Göteborg, Sweden.ORCID 0000-0001-9400-6494
Vasiliki ArapiDepartment of Pharmaceutical Biosciences, Molecular Neuropharmacology, Uppsala University, SE-751 23 Uppsala, Sweden.
Michel E MickaelDepartment of Neuroscience, Functional Pharmacology, Uppsala University, SE-751 23 Uppsala, Sweden.ORCID 0000-0002-4186-4900
Prajakta A BelekarDepartment of Metabolic Physiology, Institute of Neuroscience and Physiology, University of Göteborg, Box 430, SE-405 30 Göteborg, Sweden.
Louise GranlundDepartment of Pharmaceutical Biosciences, Molecular Neuropharmacology, Uppsala University, SE-751 23 Uppsala, Sweden.
Lakshmi KothegalaDepartment of Metabolic Physiology, Institute of Neuroscience and Physiology, University of Göteborg, Box 430, SE-405 30 Göteborg, Sweden.
Robert FredrikssonDepartment of Pharmaceutical Biosciences, Molecular Neuropharmacology, Uppsala University, SE-751 23 Uppsala, Sweden.
Sonchita BagchiDepartment of Pharmaceutical Biosciences, Molecular Neuropharmacology, Uppsala University, SE-751 23 Uppsala, Sweden.ORCID 0000-0001-7235-3372
Uppsala University · SEUniversity of Gothenburg · SE

Funding

Åhlens foundation SBEuropean Foundation for the Study of Diabetes EFSD_2018_Rising_StarGunvor and Josef Anérs foundation SBNovo Nordisk Fonden NNF17OC0027038O. E. och Edla Johanssons Vetenskapliga Stiftelse Edla_2019Stiftelsen för Strategisk Forskning 864224Stiftelsen Olle Engkvist Byggmästare SBThurings Foundation for metabolic research SBTore Nilssons foundation SBVetenskapsrådet Robert_Fredriksson
6 · The paper itself

Abstract

SLC38A6 (SNAT6) is the only known member of the SLC38 family that is expressed exclusively in the excitatory neurons of the brain. It has been described as an orphan transporter with an unknown substrate profile, therefore very little is known about SNAT6. In this study, we addressed the substrate specificity, mechanisms for internalization of SNAT6, and the regulatory role of SNAT6 with specific insights into the glutamate-glutamine cycle. We used tritium-labeled amino acids in order to demonstrate that SNAT6 is functioning as a glutamine and glutamate transporter. SNAT6 revealed seven predicted transmembrane segments in a homology model and was localized to caveolin rich sites at the plasma membrane. SNAT6 has high degree of specificity for glutamine and glutamate. Presence of these substrates enables formation of SNAT6-caveolin complexes that aids in sodium dependent trafficking of SNAT6 off the plasma membrane. To further understand its mode of action, several potential interacting partners of SNAT6 were identified using bioinformatics. Among them where CTP synthase 2 (CTPs2), phosphate activated glutaminase (Pag), and glutamate metabotropic receptor 2 (Grm2). Co-expression analysis, immunolabeling with co-localization analysis and proximity ligation assays of these three proteins with SNAT6 were performed to investigate possible interactions. SNAT6 can cycle between cytoplasm and plasma membrane depending on availability of substrates and interact with Pag, synaptophysin, CTPs2, and Grm2. Our data suggest a potential role of SNAT6 in glutamine uptake at the pre-synaptic terminal of excitatory neurons. We propose here a mechanistic model of SNAT6 trafficking that once internalized influences the glutamate-glutamine cycle in presence of its potential interacting partners.

Indexed as

Amino Acid Transport Systems, NeutralAnimalsCaveolinsCell LineGene Expression RegulationGene Knockdown TechniquesGlutamic AcidGlutamineImmunohistochemistryMiceModels, BiologicalModels, MolecularNerve Tissue ProteinsProtein BindingProtein ConformationProtein Interaction Domains and MotifsAmino Acid Transport Systems, NeutralCaveolinsGlutamic AcidGlutamineNerve Tissue ProteinsRNA, Small InterferingSNAT6 protein, mouseSodiumcaveolinendocytosisexcitatory neuronsglutamate–glutamine cycleNa+-dependent transporterpre-synaptic terminalSNAT6solute carrier proteins

Identifiers

PMID33503881
PMCPMC7865731
OpenAlexW3121835563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.